CONRIG PHARMA APS has a total of 19 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are IMARA INC, ZHUHAI EBANG PHARMACEUTICAL CO LTD and WUHAN DOCAN PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | United States | 2 | |
#8 | Brazil | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Hansen John Bondo | 16 |
#2 | Thomsen Mikael S | 8 |
#3 | Skjaerbaek Niels | 6 |
#4 | Højgaard Bent | 4 |
#5 | Thomsen Mikael Soendergaard | 3 |
#6 | Hojgaard Bent | 3 |
#7 | Thomsen Mikael Søndergård | 3 |
#8 | Bondo Hansen John | 3 |
#9 | Sondergard Thomsen Mikael | 2 |
#10 | Skjerbek Niels | 1 |
Publication | Filing date | Title |
---|---|---|
CA3073866A1 | Composition comprising suplatast tosilate | |
AU2016377872A1 | Suplatast tosilate for treating cough associated with interstitial lung disease | |
WO2017032384A1 | Compound and use in the treatment of cough | |
BR112013002846A2 | deuterated tandospirone derivatives as 5-ht1a receptor agonist |